Skip to content

Michele Barry, MD

NPI 1407839632ActiveIndividual· Internal Medicine· Stanford, CA

Internal Medicine (MD) in Stanford, California, licensed in CA and CT, with an NPI issued in November 2005. Part D covered 28 prescriptions written in 2024, 79% of them generic. Takeda Pharmaceuticals U.S.A., Inc. reported $47.21 in payments in 2025, mostly food and beverage.

Overview

NPI1407839632
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedNov 22, 2005
Last updated in NPPESApr 17, 2024
Certified by providerApr 17, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine Primary207R00000XG88539CA
Internal Medicine207R00000X021536CT

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (CA)

Part D prescriptions in 2024

Prescriptions (claims)28 · 29 30-day fills
Patients16
Total drug cost$2,346
Generic share79% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$47.21 · 2 payments from 1 company
  • 2024$18.04 · 1 payment from 1 company

Top paying companies in 2025

CompanyAmountPayments
Takeda Pharmaceuticals U.S.A., Inc.$47.212

What the 2025 payments were for

  • Food and Beverage$47.21 · 2 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other internal medicine physicians in Stanford

All 394 internal medicine physicians in Stanford · All internal medicine physicians in California